TY - JOUR T1 - Tau spreading is driven by neuronal connectivity in primary tauopathies - evidence from tau-PET and histopathology JF - medRxiv DO - 10.1101/2021.08.16.21261523 SP - 2021.08.16.21261523 AU - Nicolai Franzmeier AU - Matthias Brendel AU - Leonie Beyer AU - Gabor Kovacs AU - Thomas Arzberger AU - Carolin Kurz AU - Gesine Respondek AU - Milica Jecmenica Lukic AU - Davina Biel AU - Anna Rubinski AU - Lukas Frontzkowski AU - Anika Finze AU - Carla Palleis AU - Emanuel Joseph AU - Endy Weidinger AU - Sabrina Katzdobler AU - Mengmeng Song AU - Gloria Biechele AU - Maike Kern AU - Maximilian Scheifele AU - Boris-Stephan Rauchmann AU - Robert Perneczky AU - Michael Rullman AU - Marianne Patt AU - Andreas Schildan AU - Henryk Barthel AU - Osama Sabri AU - Jost J. Rumpf AU - Matthias L. Schroeter AU - Joseph Classen AU - Victor Villemagne AU - John Seybl AU - Andrew W. Stephens AU - Edward B. Lee AU - David G. Coughlin AU - Armin Giese AU - Murray Grossman AU - Corey T. McMillan AU - Ellen Gelpi AU - Laura Molina-Porcel AU - Yaroslau Compta AU - John C. van Swieten AU - Laura Donker Laat AU - Claire Troakes AU - Safa Al-Sarraj AU - John L. Robinson AU - Sharon X. Xie AU - David J. Irwin AU - Sigrun Roeber AU - Jochen Herms AU - Mikael Simons AU - Peter Bartenstein AU - Virginia M. Lee AU - John Q. Trojanowski AU - Johannes Levin AU - Günter U. Höglinger AU - Michael Ewers AU - For the German Imaging Initiative for Tauopathies (GII4T) & the Alzheimer’s Disease Neuroimaging Initiative Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/23/2021.08.16.21261523.abstract N2 - Tau pathology is the main driver of neuronal dysfunction in 4-repeat tauopathies (4RT), including cortico-basal degeneration and progressive supranuclear palsy (PSP). Tau is assumed to spread prion-like across connected neurons, but the mechanisms of tau propagation are largely elusive in 4RTs, characterized not only by neuronal but also by astroglial and oligodendroglial tau accumulation. Here, we assessed whether connectivity drives 4R-tau spreading patterns by combining resting-state fMRI connectomics with both 2nd generation 18F- PI-2620 tau-PET in 46 patients with clinically diagnosed 4RTs and post-mortem cell-type- specific regional tau assessments from two independent PSP samples (n=97/96). We found that inter-regional connectivity was associated with higher inter-regional correlation of both tau- PET and post-mortem tau levels in 4RTs. In regional cell-type specific post-mortem tau assessments, this association was stronger for neuronal than for astroglial or oligodendroglial tau, suggesting that connectivity is primarily associated with trans-neuronal tau spread. Using tau-PET we found that patient-level tau patterns can be predicted by the connectivity of subcortical tau epicenters. Together, the current study provides combined in vivo tau-PET and histopathological evidence for brain connectivity as a key mediator of trans-neuronal tau spreading in 4RTs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe wish to thank the patients and their families, without whose support and altruism this research would not have been possible. Further, we would like to acknowledge Prof. Christian Haass (DZNE, Munich) for his consultation on study design, the European Reference Network for Rare Neurological Diseases - Project ID No 739510 and the Neurological Tissue Bank of the Biobanc-Hospital Clinic-IDIBAPS for sample and data procurement. This work was supported by the NIH (P30AG010124, P01AG066597, U19AG062418, R01-NS109260), the National Center for Advancing Translational Sciences (TL1TR001880), the German Research Foundation (DFG; SCHR 774/5-1, DFG, INST 409/193-1 FUGG) the SyNergy excellence cluster (EXC 2145/ID 390857198). NF was supported by the Hertie foundation for clinical neurosciences. GGK is supported by the Rossy Foundation and Safra Foundation. GH was funded by the Deutsche Forschungsgemeinschaft (DFG, HO2402/18-1 MSAomics), the German Federal Ministry of Education and Research (BMBF, 01EK1605A HitTau), VolkswagenStiftung and Lower Saxony Ministry for Science (Niedersaechsisches Vorab), Petermax-Mueller Foundation (Etiology and Therapy of Synucleinopathies and Tauopathies). MB was supported by the Hirnliga e.V. (Manfred-Strohscheer-Stiftung) and by the Alzheimer Forschung Initiative e.V. (grant number #19063p).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The 18-F-PI2620 PET imaging protocol was approved by local ethics committee of the LMU Munich. Written informed consent was obtained from all participants. The full study protocol including all samples and all PET data analyses were approved by the local ethics committee (LMU Munich, application numbers 17-569 and 19-022) and the German radiation protection (BfS-application: Z 5 - 22464/2017-047-K-G) authorities. The study was carried out according to the principles of the Helsinki Declaration. The post-mortem examinations of brain tissue in PSP patients were approved by the ethics committee of the medical faculty of the university of Marburg, Germany. All work complied with ethical regulations for work with human participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on reasonable request from the corresponding author. ER -